Latest news
- Beating Blood Cancers Blog
- Our publications
- Disease newsletters
- Leukaemia Foundation News
- Lifeblood
- Lymphoma e-News
- Meet Geoff
- Q & A with Dr Peter Diamond – our Head of Research
- Talking lymphoma with Associate Professor Jake Shortt
- Geoff feels blessed to be on a trial and never wastes a day
- Searching for biomarkers and better treatments for B-cell lymphomas
- Shine a light on blood cancer at Light the Night
- Could the immune system hold the key to curing follicular lymphoma?
- Life’s good for Michael thanks to Ibrutinib
- Max’s story: living well with mantle cell lymphoma
- New insights in non-hodgkin lymphoma
- What’s CAR T-cell therapy?
- Living Well e-News
- Cancer-related fatigue – what it is, how it can affect you and how to manage it
- Cherryl meditates to reduce stress and for her healing
- Cooking for chemo recipes: comfort food for winter
- Talking humanity in healthcare with David Joske
- Tereena goes to her “happy place” when she’s in pain or discomfort
- The mind/body connection in healing
- MDS e-News
- Subscribe
- Latest news
- Social media
- Videos
- Media contacts
Leukaemia Foundation supports better access to clinical trials for all Australians
Friday, 3 May 2019
The Leukaemia Foundation says recent commitments from each major political party to support better access to clinical cancer trials are a pivotal step toward improving outcomes for Australians living with blood cancers.
The Leukaemia Foundation has welcomed the latest $100 million commitment from the Federal Government to
Federal Health Minister Greg Hunt commits to Blood Cancer Taskforce and Action Plan
Wednesday, 17 April 2019
The Leukaemia Foundation welcomes the commitment from the Federal Health Minister Greg Hunt to establish a Blood Cancer Taskforce and Action Plan.
The Blood Cancer Taskforce will work with leading clinicians, researchers and patient groups in the blood cancer community to
Leukaemia Foundation supports Labor’s $20 million blood cancer Right to Trial
Wednesday, 17 April 2019
The Leukaemia Foundation welcomes Federal Labor’s commitment of $20 million to give Australian blood cancer patients faster access to leading clinical trial drugs and therapies through a new Right to Trial program.
Leukaemia Foundation CEO Bill Petch today joined Opposition Leader Bill Shorten and Shadow Health Minister for Health and Medicare Catherine King at
South Australian researchers to develop cutting edge genetic testing
Tuesday, 16 April 2019
The Leukaemia Foundation is funding a cutting-edge diagnostic test that would help clinicians identify specific gene mutations to offer more effective, targeted treatments for Australians living with blood cancer.
The SA Genomics Haematology Malignancies Node will have the first of three tests available across Australia in six
CAR-T therapy receives Federal Government funding allowing young people with ALL to receive innovative treatment
Monday, 15 April 2019,
The Leukaemia Foundation has welcomed today’s announcement by Federal Health Minister Greg Hunt to list CAR-T therapy on the Medicare Benefits Schedule (MBS). The treatment will be for use in paediatric and young adult patients up to 25 years of age with B-cell precursor acute lymphoblastic leukaemia (ALL) that is refractory, in relapse post-transplant,
Welcome commitment to reduce out-of-pocket cancer costs
Friday, 05 April 2019
The Leukaemia Foundation welcomes Federal Labor’s commitment to reducing out-of-pocket costs for cancer patients as part of a $2.3 billion funding package announced in last night’s Federal Budget reply.
The announcement includes funding to remove out-of-pocket costs associated with diagnostic imaging, bulk-billed Medicare items for oncologists and specialist surgeons,
New PBS listing vital to Australians living with B-cell Acute Lymphoblastic Leukaemia
Thursday, 4 April 2019
The Leukaemia Foundation has welcomed news Australians living with B-cell acute lymphoblastic leukaemia (B-ALL) will have access to the drug inotuzumab ozogamicin (Besponsa®) through the Pharmaceutical Benefits Scheme (PBS) after the listing was announced in this week’s Federal Budget.
According to the Federal Government, Australians living with
New Australian facilities announced for break-through CAR-T therapy and other immunotherapy clinical trials
Tuesday, 26 March 2019
The Leukaemia Foundation welcomes the federal government $80 million investment to establish the Peter MacCallum Centre as a new base for Car-T Cell therapy and other immunotherapy clinical trials in Australia.
The funding package would help to build 2,600 square met facilities to manufacture commercial CAR-T
Leukaemia Foundation to partner with Tour de Cure for the inaugural Life Ride
Tuesday, 26 March 2019
The Leukaemia Foundation and Tour de Cure will combine forces in 2019 to host the first Life Ride – an inspiring three-day cycling event to help fund research and find a cure for blood cancer.
The inaugural Life Ride will be held in the spectacular Margaret River region of Western Australia from Sunday,
Treatment for cutaneous T-cell lymphomas to be subsidised through broadened PBS listing
Thursday, 21 March 2019
The Leukaemia Foundation welcomes the Federal Government’s announcement that the Pharmaceutical Benefits Scheme (PBS) listing of brentuximab vedotin (Adcetris®) will be broadened to include treatment of cutaneous T-cell lymphomas (CTCL) from 1 April 2019.
CTCL is a type of non-Hodgkin lymphoma that directly attacks the body’s T-cells, a type of white